secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001493152-23-005216
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions Q2 net loss narrows to $0.42M; govt support income up 52%
--------------------------------------------------------------------------------

- Net loss of $0.42M ($0.46/shr) vs $3.46M ($4.65/shr) in prior year period.
- Government support income rose 52% to $269,625 on R&D qualifying expenditures.
- Cash and equivalents $2.9M at quarter-end; successful completion of Milestone 7 biosensor phase.
- Milestone 7 achieved 4x improvement in time-to-result, enabling under-one-minute test.
- Partnered with Boughey Distribution and Hozelock for fingerprint drug testing programs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223005216/0001493152-23-005216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315223005216/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer